Pneumocystis Pneumonia | Appendix B: Panel Roster and Financial Disclosures | Adult and Adolescent Opportunistic Infection | ClinicalInfo

Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.

Appendix B: Panel Roster and Financial Disclosures

Pneumocystis Pneumonia

*Pneumocystis* Pneumonia
Member		Financial Disclosure
Member		Company	Relationship
Crothers, Kristina	Yale University School of Medicine	American Lung Association	Research Support
Crothers, Kristina	Yale University School of Medicine	National Institutes of Health	Research Support
Furrer, Hansjakob	Universitatsspital Bern, Switzerland	Association contre le VIH et autres infections tranmissibles	Research Support
		Gilead	Research Support
		Swiss HIV Research Foundation	Research Support
		Swiss National Science Foundation	Research Support
Helweg-Larsen, Jannik	Rigshospitalet, Copenhagen University, Denmark	None	N/A
Huang, Laurence	University of California, San Francisco	None	N/A
Kalapila, Aley	Emory University	None	N/A
Kovacs, Joe*	National Institutes of Health	Matinas BioPharma	Research Support
Kovacs, Joe*	National Institutes of Health	Merck	Research Support
Miller, Robert	University College London, England	British HIV Association	Research Support
Miller, Robert	University College London, England	Gilead	Honoraria, Speaker's Bureau
Morris, Alison	University of Pittsburgh Medical School	Gilead	Research Support
* Group Lead Note: Members were asked to disclose all relationships from 12 months prior to the updated date. The period of reporting was from August 1, 2018, through August 1, 2019.

Updated

Aug. 01, 2019

Reviewed

Aug. 01, 2019

Download Guidelines

Section OnlyPDF (556.88 KB)
Full GuidelinePDF (3.78 MB)
Tables OnlyPDF (481.21 KB)